Literature DB >> 20451704

Red yeast rice and statin-intolerant patients.

Arrigo F G Cicero, Giuseppe Derosa, Claudio Borghi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451704     DOI: 10.1016/j.amjcard.2010.01.337

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

1.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Arch Med Sci       Date:  2017-08-04       Impact factor: 3.318

2.  Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.

Authors:  Arrigo F G Cicero; Alessandra Reggi; Angelo Parini; Martino Morbini; Martina Rosticci; Elisa Grandi; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-04-12

3.  Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Arrigo F G Cicero; Cormac Kennedy; Tamara Knežević; Marilisa Bove; Coralie M G Georges; Agnė Šatrauskienė; Peter P Toth; Federica Fogacci
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

Review 4.  Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Authors:  Arrigo F G Cicero; Federica Fogacci; Anca Pantea Stoian; Michal Vrablik; Khalid Al Rasadi; Maciej Banach; Peter P Toth; Manfredi Rizzo
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.